Nephrology Videos
Advertisement
Michael Spigler of the American Kidney Fund spoke with Nephrology Times about the Unknown Causes of Kidney Disease Project.
ANNA's national president spoke about its support for nephrology nurses and the upcoming 2024 Nephrology Nursing Summit.
Hilary Hatch discussed a survey finding that patient-provider conversations and patient activation play a key role in CKD.
Dr. Charles Vega spoke with Nephrology Times about the disproportionate chronic kidney disease burden among Latinos.
Anjay Rastogi, MD, PhD, spoke about findings from the ZORA study regarding the efficacy of SZC for hyperkalemia.
Xiaoxi Wei of X-Therma spoke about her company's preservation platform and how it can change organ transplantation.
Nephrology Times spoke with Fadi Fakhouri, MD, PhD, about results from the NOBLE trial of pegcetacoplan for C3G and ICMPGN.
A study by Suphamai Bunnapradist and others found that dd-cfDNA is an early indicator of kidney transplant rejection.
Cesia Portillo discussed her poster on creating a roadmap for APOL1-mediated kidney disease (AMKD).
Suzanne Watnick shared thoughts on the Shaul G. Massry lectureship, COVID-19, kidney transplantation, and policy issues.
A. Ersin Yassa and Yasemin Balin were the winners of the inaugural Neph Madness tournament.
Martin Pollak reflected on winning the David M. Hume Memorial Award and on breakthroughs in glomerular diseases.
Sylvia Rosas shared highlights from her term as president of the National Kidney Foundation.
Bhupinder Singh and Stewart Turner discussed serum bicarbonate concentrations in patients with CKD and metabolic acidosis.
Michael Spigler of American Kidney Fund discussed its work and its findings on education level and transplant discussions.
Areef Ishani spoke about his abstract on renal outcomes with chlorthalidone versus hydrochlorothiazide for hypertension.
Dr. Chee Kay Cheung discussed two presentations on IgA nephropathy findings from the SPARTAN and PROTECT studies.
Dr. Robert Montgomery spoke about advances in xenotransplantation, including the pig kidney transplant he recently performed.
Dr. Dana Rizk discussed her APPLAUSE-IgAN study findings on iptacopan versus placebo for IgA nephropathy.
Dr. Mohamed G. Atta discussed the importance of educating clinicians about Fabry disease.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC, a Formedics Property. All Rights Reserved.